Bernstein, Jonathan A <br/><br/>
Population pharmacokinetics of plasma-derived C1 esterase inhibitor concentrate used to treat acute hereditary angioedema attacks.  [electronic resource] 

 -  Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology  Aug 2010 
 - 149-54 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1081-1206 
<br/><br/><label>Standard No.: </label>10.1016/j.anai.2010.06.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Child<br/>Complement C1 Inhibitor Protein--administration & dosage<br/>Half-Life<br/>Hereditary Angioedema Types I and II--blood<br/>Humans<br/>Middle Aged<br/>Models, Biological<br/>Population Groups<br/>Retrospective Studies